MassBio’s Annual Policy Leadership Breakfast Addresses Efforts to Lower Prescription Drug Costs

Jan 24, 2019

Invite-only event convenes policymakers, industry leaders and other key stakeholders to debate 2019 policy initiatives

What: MassBio’s annual Policy Leadership Breakfast brings together senior industry leaders, policymakers, and life sciences government affairs executives to discuss the most pressing policy initiatives impacting the industry. Through a panel discussion, the event will address state and federal government proposals to lower prescription drug costs in Medicaid and Medicare, including using value frameworks in Medicaid, international reference pricing in Part B, and eliminating protected classes in Part D. MassBio will also honor Rep. Joseph Wagner (D – 8th Hampden District) with the 2018 Legislator of the Year Award, and Kevin O’Sullivan, immediate past president of the Massachusetts Biomedical Initiative (MBI), with the Lifetime Achievement Award.

When: Wednesday, January 30, 2019 from 8am – 10am ET

Where: Omni Parker House, 60 School St. Boston, MA 02108

Who: Moderators Bruce Mohl, editor of CommonWealth Magazine, will be joined by panelists:

  • Meg Alexander, Head, Reputation & Risk Management Practice, Syneos Health
  • Patrick Plues, Vice President, State Government Affairs, BIO
  • Tamar Thompson, Executive Director, State Government Affairs/Alliance Development & Federal Payment Policy, Bristol-Myers Squibb
  • Kristin Wolff, Director, Global Government Affairs and Public Policy, bluebird bio
  • Walter Whitt, Harvard University student and patient with Cystic Fibrosis

Interested media can register for free by contacting Jennifer Nason.

See all MassBio News